Skip to main content
Taylor & Francis Open Select logoLink to Taylor & Francis Open Select
. 2021 Jan 28;22(5-6):350–359. doi: 10.1080/21678421.2021.1874991

Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS)

Vanessa Halliday 1,, Nicolò Zarotti 2, Elizabeth Coates 1, Alexander McGeachan 2, Isobel Williams 3, Sean White 4, Daniel Beever 1, Paul Norman 3, Sarah Gonzalez 1, Gemma Hackney 1, Naseeb Ezaydi 1, Theocharis Stavroulakis 2, Mike Bradburn 1, Christopher McDermott, on behalf of the HighCALS Study Group2
PMCID: PMC8312499  PMID: 33507093

Abstract

Abstract

Objectives

The aim of this study was to investigate how nutritional management services for people with Amyotrophic Lateral Sclerosis (pwALS) are structured in the UK, in order to gain insight into current practice and identify key barriers and enablers to delivering and providing services. Methods: A three-part, sequential mixed-methods study was conducted that comprised (i) a thematic analysis of data from five focus groups (with 47 ALS health professionals from 41 UK organizations and four service user representatives), (ii) a nationwide cross-sectional survey (281 ALS healthcare professionals) and (iii) a freedom of information request (251 organizations). Results: UK nutritional management services for pwALS are coordinated from specialist (n = 22) and non-specialist care centers (n = 89), with national variability in the organization and delivery of services. Multidisciplinary working was highlighted to facilitate the coordination of nutritional care. However, the need to provide evidence-based continuing education for HCPs was evident. Overall, the lack of clear guidelines on the nutritional management of people with ALS was identified as a key barrier to the delivery of effective nutritional care, as was the lack of transparency and consistency in the commissioning of nutritional services. Further concerns over the timeliness of the dietetic intervention and equity of access and provision were raised. Conclusions: Our findings suggest that development of guidelines for nutritional management, particularly at diagnosis and pre-gastrostomy, could drive standardization of high quality nutritional care for pwALS. Such guidance has the potential to reduce inequalities in geographical provision by providing clarity for those commissioning specialist nutrition services.

Keywords: Nutrition management, health services, mixed methods, amyotrophic lateral sclerosis, motor neuron disease

Introduction

Weight loss is commonly reported in people with amyotrophic lateral sclerosis (pwALS) with a higher body mass index (BMI) and obesity believed to have beneficial prognostic effects (1–3). Furthermore, prevention of weight loss can positively impact quality of life, particularly with regards to reducing levels of fatigue (4).

Despite the complex etiology of malnutrition, there is evidence that provision of nutritional support is of benefit (4–6). Although international ALS nutritional guidelines identify the importance of addressing dysphagia and the timing and method of gastrostomy insertion (7–10), guidance on nutritional management with regard to assessment of nutritional status, appropriate dietary intake or oral nutritional supplementation is lacking. There is a dearth of evidence-based guidance specific to the structure and delivery of nutritional management services for newly diagnosed pwALS. Moreover, surveys of healthcare professionals (HCPs) have highlighted the lack of evidence and knowledge regarding nutritional management of ALS as a concern (11–13).

In the UK, nutritional management is a research priority for pwALS (14). An improved understanding of the organization of nutritional management services, from diagnosis and throughout the disease course, could guide interventions, thus preventing the negative consequences of weight loss and subsequent malnutrition. The aim of this study was to investigate how nutritional management services for pwALS are structured in the UK, to explore current practice and identify barriers and enablers to provision.

Methods

Study design

A mixed-methods approach was chosen due to the complexity of the issue under investigation, involving various national stakeholders. Qualitative data was used to provide contextual understanding to quantitative findings and to facilitate investigation of different aspects of nutritional management services. The mixed-methods approach has been found to be powerful in health services research (15,16).

This was a three-part exploratory sequential study comprising: (i) focus groups (FGs) with ALS HCPs in different locations across the UK, (ii) a nationwide cross sectional survey of ALS HCPs and (iii) freedom of information requests sent to UK healthcare organizations.

Part 1 qualitative focus groups

Participants

UK healthcare professionals involved in ALS care and service user representatives were invited to participate in focus groups. A range of organizations were contacted including the Motor Neurone Disease Association (MNDA), MND Scotland, British Dietetic Association (BDA), UK Motor Neurone Disease Clinical Studies Group, and Sheffield Motor Neurone Disorders Research Advisory Group. In addition, MND Care Centers, Clinical Commissioning Groups (CCGs), and MND Regional Care Development Advisers were approached. Invitation emails were distributed to contacts, and study information was advertised on Twitter. Convenience sampling methods were used, whereby eligible and potentially interested participants were asked to opt-in based on their availability to attend one of the focus groups, and to maximize sample variation in terms of clinical specialties, job roles and geographical locations.

Data collection

Focus groups were conducted in June 2018 and held at easily accessible non-NHS sites throughout the UK. Each focus group discussion was divided into three sections. In section one, the groups were asked “How important is it to provide nutritional advice and support to pwALS?” to encourage open discussion. Section two involved a small-group elicitation exercise whereby participants were asked to record summary information to allow the study team to produce descriptive accounts of commissioning and guidance, service structure, and interventions to inform the survey design. Section three was an exploratory discussion of barriers and enablers to delivering nutritional management services. The focus group discussions from sections one and three were audio recorded. Two members of the research team (EC, AM) facilitated the FGs, with support from others (IW, DB, GH).

Analysis

Recordings were transcribed verbatim and analyzed thematically (17). This began with data familiarization, to develop a preliminary list of codes. Following multiple revisions by three team members (NZ, AM, LC), codes were distilled into four overarching and distinctive themes on which all the members of the team agreed, two of which are presented here (the other two themes are presented elsewhere (18)).

Part 2 cross-sectional survey

The survey, hosted online via Qualtrics, included a set of questions structured under eight headings: (1) demographic information about participant role and care location, (2) involvement with pwALS, (3) multidisciplinary team (MDT) working, (4) nutrition knowledge and skills, (5) nutrition and dietetic services, (6) nutritional screening, (7) nutritional management and (8) commissioning and funding of ALS services. As dietetic practice was of specific interest, additional questions related to nutritional assessment and treatment of patients were asked through conditional branching (findings reported elsewhere (19)). The majority of questions quantitatively explored the knowledge and attitudes of participants. Prior to dissemination, the survey was piloted locally with nine healthcare professionals.

Participants

Healthcare professionals working in the UK with current or recent involvement in ALS clinical or community care were eligible to participate. The survey was distributed electronically to known contacts and via gatekeepers at UK MND Care Centers, NHS Trusts, the MNDA, and through profession specific networks (National Nurses Nutrition Group, and specialist groups of the BDA: Neurosciences Specialist Group, and Parenteral and Enteral Nutrition Group). It was also publicized via social media, websites, and newsletters. Focus group participants who consented to be contacted about future research were sent the survey directly.

A snowballing technique was used to distribute the survey to HCPs across geographical areas. To maximize the response rate, two reminders and an incentive prize draw were included. The survey was open between 19 September and 14 November 2018.

Data analysis

Findings were analyzed in SPSS and summarized descriptively.

Part 3 freedom of information requests

Freedom of Information (FOI) teams at UK NHS Hospital Trusts and Clinical Commissioning Groups (CCGs) were contacted via email, requesting information about services provided for pwALS. The questions addressed the size, structure, and location of the ALS service, dietetic provision, and commissioning of ALS nutrition services. Prior to dissemination, the FOI questions were piloted locally.

Ethics

Ethical approval for this study was granted by the Research Ethics Committee of the School of Health and Related Research at the University of Sheffield (ref: 018781), and governance approval was granted by the Health Research Authority (ref: 245296). All focus group participants provided written informed consent. The survey included a participant information section and questions documenting consent to participate.

Results

Sample characteristics

There were 51 participants across the five focus groups. The number of participants at each focus group varied from seven to a maximum of 13. The mean duration of the discussions was 60 minutes (range from 55 to 65 minutes).

In total, 281 participants completed the survey. Participants had been in their post for a mean of seven years (SD = 6.2), with 9.8 years mean experience (SD = 7.4) working with pwALS. The majority (67.8%) reported that patients with ALS were less than 20% of their caseload.

Of the 433 organizations contacted, 379 (87.5%) responded within the seven-week deadline. The FOI request was relevant for 251 (66.2%) of these organizations, 109 (43.4%) of which were Health Boards or NHS Trusts that provided healthcare services for pwALS. Twenty-two (8.8%) stated that they were a specialist care center.

Participant details are shown in Tables 1 and 2.

Table 1.

Participant professions.

  Focus groups n (%) Survey n (%)
Dietician 25 (49%) 130 (46%)
Nurse 11 (22%) 56 (20%)
Speech and language therapist 6 (12%) 35 (12%)
Service user 4 (8%) 0
MND coordinator 2 (4%) 4 (1%)
Doctor 2 (4%) 34 (12%)
Physiotherapist 1 (2%) 11 (4%)
Occupational therapist 0 10 (4%)
Psychologist 0 1 (<1%)
Total 51 281

Table 2.

Summary of organizations responding to FOI request.

Organization Response frequency (%) n = 251 Number that commission or provide healthcare services for pwALS
Clinical commissioning groups 114 (45%) 14
 London 18 1
 Midlands and East 43 6
 North 28 3
 South East 19 2
 South West 6 2
Health boards 21 (8%) 20
 Northern Ireland 5 5
 Scotland 10 9
 Wales 6 6
NHS Trusts in England 114 (45%) 89
 London 18 15
 Midlands and East 29 22
 North 34 22
 South East 17 16
 South West 16 14
Non-NHS 2 (<1%) 2
 London 1 1
 Nationwide 1 1

Identified themes

Two overarching and distinctive themes in relation to the organization of ALS services in the UK were identified across the three parts of the study. The first theme concerned the determinants of quality healthcare and issues related to timely and effective care. The second concerned the importance of organization and team working, and how improving communication at different organizational levels could improve the delivery of effective nutritional care. The results have been integrated into a narrative to describe each theme, drawing on the qualitative themes from the focus groups and triangulated with data from the survey and FOI requests. Table 3 shows a selection of illustrative quotes from the focus groups to support each of the sub-themes. Tables 4 and 5 show summary statistics from the survey and FOI request, respectively.

Table 3.

Illustrative quotes from focus groups.

Theme Illustrative quote(s)
Determinants of quality care  
 MND dietetic services “I think the earlier we can get in there and help provide reassurance and advice and guidance, then I think we can do a better job. And the sooner we get to know people and provide that advice earlier I think do better toward the end when things can get more complicated, cos you’ve got the relationship, you’ve got the knowledge of the patient, the family. The sooner you can start to develop that, the more appropriate everything you do is gonna be.” – Focus group 1
“As dieticians we end up getting involved at crisis point.” – Focus group 3
 Setting of ALS care delivery “Community service is so important because it’s no point bringing someone into an appointment, that’s not what you do at home that, you know, I want to see where you are sitting and how you’re sitting and how much your food is given and what else is going on. So you can’t really judge how someone’s physically managing.” – Focus Group 3
 Nutrition knowledge and skills “I’m not looking for anything that is prescriptive, but it would be nice to have a bit more guidance, a bit more evidence behind things.” – Focus Group 2
“Part of that [nutritional management] is developing the relationship, isn’t it? If you’ve got a relationship, trust with your patient, that really, really helps. But it can take time to kind of develop that, can’t it […] because you can’t have those difficult conversations when you’ve just met.“ – Focus Group 3
“like a sort of national tool kit that can be adopted by any trust” – Focus Group 2
 Commissioning of ALS services “Yeah, there’s a huge gap for the whole of neurology services for nutrition.” – Focus Group 1
“There is a certain amount of discretion where a manager will say ‘we’re not actually funded to do this, but I want you to go out and I want you to go and see these people’, and that is something that enables the service. In other departments they might say ‘we’re not funded for that, you’re not seeing those people’.” – Focus Group 1
“Part of the issue is that the tariff… depending on where you are, the tariff is being based at the clinic tariff, and that’s just whether you’re hospital or community for that matter, and actually it’s just illogical, given the complexity of the patients. So part of the money would come about if it was commissioned as a specialist clinic and specialist service.” – Focus Group 3
 Organization and MDT working “Having a specific MND MDT team is a huge advantage, because it’s not just the dietician that’s really key for nutritional support to management, it’s the whole of the team.” – Focus Group 2

Table 4.

Summary of findings from survey.

  Responses n (%)
Involvement with ALS services  
Do you currently provide care to people with motor neurone disease (MND)? 281
  Yes 255 (90.7)
  No, but I have in the past 23 (8.2)
  No 3 (1.1)
Approximately, what percentage of your total caseload at present are patient with MND? 255
  0–20% 173 (67.8)
  21–40% 42 (16.5)
  41–60% 6 (2.4)
  61–80% 6 (2.4)
  81–100% 28 (10.9)
ALS patients represent 20% or less of caseload based on profession  
  Dieticians (n = 130) 102 (78.5)
  Doctors (n = 34) 24 (70.6)
  Nurses (n = 56) 32 (57.1)
  Occupational therapists (n = 10) 6 (60)
  Physiotherapists (n = 11) 8 (72.7)
  Speech and language therapists (n = 35) 18 (51.4)
Where is/was that care delivered? 278
  Patient’s homes 185 (66.6)
  Palliative care centers/hospices 115 (41.3)
  Hospital inpatients services 113 (40.6)
  Hospital outpatients specialist ALS clinics 73 (26.2)
  Community GP clinics 10 (3.6)
  Hospital outpatients general clinics 45 (16.1)
  Hospital outpatients neurology clinics 17 (6.1)
MND multidisciplinary team (MDT) working  
Do you consider yourself to work as part of a MND MDT? 281
  Yes 214 (76.1)
  Unsure 10 (3.6)
  No 57 (20.3)
If no, is there a MND MDT within your organization? 57
  Yes 35 (61.4)
  No/Unsure 22 (38.6)
How do you interact with the MND MDT? 214
  Regular attendance at MDT meetings 118 (55.1)
  Regular attendance of specialist clinics 56 (26.2)
  Written/verbal communication when required 139 (64.9)
How effective is communication within MDT regarding nutritional management of MND patients? 281
  Not at all effective 4 (1.4)
  Slightly effective 24 (8.5)
  Moderately effective 104 (37)
  Very effective 116 (41.3)
  Extremely effective 33 (11.7)
How well coordinated is the approach to nutritional management within your locality? 281
  Uncoordinated 20 (7.1)
  Not very well coordinated 38 (13.5)
  Moderately well-coordinated 114 (40.6)
  Very well coordinated 99 (35.2)
  Extremely well-coordinated 10 (3.6)
Nutrition knowledge and skills  
Have you ever provided nutritional advice to MND patients or their carers? 281
  Yes 246 (87.5)
  No 35 (12.5)
If yes, do you base your nutritional advice on set guidelines or standards? 246
  Yes 143 (58.1)
  No/Unsure 103 (41.9)
Which guidelines or standards do you use? 143
  Motor Neurone Disease Association (MNDA) 118 (82.5)
  National Institute for Health and Care Excellence (NICE) 116 (81.1)
  Parenteral and Enteral Nutrition Group (PENG) 83 (58)
  British Association for Parenteral and Enteral Nutrition (BAPEN) 69 (48.3)
  Locally developed NHS Trust guidelines 63 (44.1)
  European Society for Enteral and Parenteral Nutrition (ESPEN) 25 (17.4)
How do you rate your level of knowledge of nutritional issues in MND? 281
  Very poor/Poor 10 (3.6)
  Fair/Good/Excellent 271 (96.4)
How satisfied are you with your level of knowledge of nutritional issues in MND? 281
  Not at all satisfied 7 (2.5)
  Slightly satisfied 20 (7.1)
  Moderately satisfied 123 (43.8)
  Very satisfied 111 (39.5)
  Extremely satisfied 20 (7.1)
Those who reported moderate satisfaction with level of knowledge of nutritional issues in MND, based on profession  
  Doctors (n = 34) 18 (52.9)
  Dieticians (n = 130) 47 (36.1)
  Nurses (n = 56) 25 (44.6)
  Occupational therapists (n = 10) 6 (60)
  Physiotherapists (n = 11) 7 (63.6)
  Speech and language therapists (n = 35) 20 (57.1)
Funding of ALS services  
To what extent do you agree with the following statement: “there is sufficient funding for the nutritional management of patients with MND in your locality?” 281
  Strongly agree/agree 65 (23.1)
  Strongly disagree/disagree 109 (38.8)
  Neither agree nor disagree 107 (38)
What level of priority do you believe is given to commissioning services that support the nutritional management of patients living with MND? 281
  Medium to very high priority 150 (53.4)
  Low priority 114 (40.6)
  Very low priority 17 (6)

Table 5.

Findings from FOI request.

  Responses n (%)
Of the 433 organizations contacted 379
  FOI request was relevant 251 (66.2)
  Commission or provide healthcare services for pwALS 125 (49.9)
Motor Neurone Disease (MND) Services  
Is your NHS organization a specialist care center for MND? 109
  Yes 22 (20.2)
  No 87 (79.8)
In your organization, are patients with MND seen in specialist clinics? 125
  Yes 49 (39.2)
  No 76 (60.8)
If yes, how often are specialist clinics held? 49
  Weekly 10 (20.4)
  Every 2–4 weeks 19 (38.8)
  2–4 months or less frequently 18 (36.8)
  Not known 2 (4)
If yes, how often are patients routinely reviewed in MND specialist clinics? 52
  Every 2–3 months 26 (50)
  Determined by clinical need 15 (28.8)
  No formal follow up 1 (1.9)
  Every 3–6 months 10 (19.2)
MND Healthcare Team  
Who leads the MND services in your organization? 89
  Consultant neurologist 41 (46.1)
  Neuro/rehab team 9 (10.1)
  Palliative medicine consultant 7 (7.8)
  Specialist nurse/matron 7 (7.8)
  ALS coordinator / advisor 4 (4.5)
  No specific lead 21 (23.6)
Is there a multidisciplinary team (MDT) providing care for ALS patients? 97
  Yes 71 (73.2)
  No 26 (26.8)
Location of MDT 71
  In specialist care centers 21 (29.6)
  In non-specialist care centers 50 (70.4)
If yes, which professional roles are members of the MDT? 71
  Occupational therapist 66 (93)
  Dietician 56 (79)
  Physiotherapist 50 (70)
  ALS/neurology specialist nurse 42 (59)
  Speech and language therapist 39 (55)
  Neurology consultant 38 (54)
  Social worker/benefits advisor 29 (41)
  Palliative medicine consultant 23 (32)
  Psychologist 16 (23)
  Respiratory consultant 15 (21)
  Hospice representation 14 (20)
  ALS coordinator/advisor 11 (16)
  Palliative medicine nurse 10 (14)
  Community nurse 9 (13)
  Gastroenterology consultant 4 (6)
  MNDA representation 4 (6)
  Respiratory physiologist/technician 4 (6)
  Rehabilitation consultant 4 (6)
  Wheelchair advisor 4 (6)
  GP 2 (3)
  Orthotist 2 (3)
  Nutrition nurse 1 (1)
  NIV practitioner 1 (1)
  Service user 1 (1)
Do you have posts specifically funded for ALS care? 111
  Yes 38 (34.2)
  No 73 (65.8)
If yes, what type of posts are these? 38
  Specialist nurse 24 (63.1)
  ALS coordinator 20 (52.7)
  Clinical lead 8 (21)
  Dietician 7 (18.4)
  Psychologist 2 (5.2)
Commissioning of MND Nutrition Services  
Where does the funding come from for MND services in your locality? 202
  Clinical commissioning groups 107 (52.9)
  Charities 8 (4)
  No specific funding 15 (7.4)
  NHS England, Health Boards, NHS Trusts and specialist commissioning 55 (27.2)
  Information not available 17 (8.4)
Where does the funding come from for MND nutritional services in your locality? 143
  Clinical commissioning groups 86 (60.1)
  NHS England 21 (14.7)
  Department of Health 1 (0.7)
  Scottish Government 3 (2.1)
  County Council 1 (0.7)
  No specific funding 31 (21.7)

Determinants of quality healthcare

This study identified many factors that influence how healthcare services interact with ALS patients at opportune moments to impact positively upon nutritional status. The complexity of nutritional management in ALS was acknowledged by participants across focus groups.

Access to services

In the focus groups, it was apparent that access to many services and treatments for pwALS with nutritional issues varied between geographical areas and NHS Trusts. Participants believed that this created heterogeneity in care and barriers to delivering optimal nutritional management, to the point that access to services was described as “pot luck.”

Findings from the survey and FOI requests support this, highlighting inconsistency in the organization and delivery of healthcare for pwALS in the UK. Of the 49 organizations that reported that they held specialist ALS clinics, there was no standard frequency, with clinics varying between weekly and six-monthly, with 50% providing these at 2–3 month intervals and 29% being tailored according to clinical need.

ALS dietetic services

Regarding specialist dietetic care, although 89 organizations (80%) identified that they had dietitians working generically in their organization, only seven (18%) stated there was an ALS-specific funded dietitian in the MDT. During the focus groups, this variability in care was a particularly emotive topic, with reports of patients being inappropriately declined dietetic input or being removed from a dietitian’s caseload due to not meeting “hard” referral criteria (e.g. greater than 10% weight loss). This, combined with long waiting times, was seen as a key reason why pwALS were denied timely dietetic input. Many dietetic participants felt that they saw pwALS when it was too late. Again, survey responses support this, suggesting that only 31% of pwALS were referred to a dietitian at diagnosis.

Setting of ALS care delivery

The FOI requests identified that ALS care is delivered in various settings, including out-patient clinics, in-patient services, community clinics, domiciliary visits, and hospice care, with one organization using video-conferencing. The value and utility of seeing patients in their home environment to achieve an accurate understanding of how they are managing their nutrition was also highlighted during focus groups.

Nutrition knowledge and skills

Another element of quality care was the knowledge and skills of HCPs. Most non-dietetic survey respondents (87%) said that they provided nutritional advice to pwALS. Within the focus groups, nurse specialists were reported to play a pivotal role in nutritional management. The importance of HCPs' skills and knowledge to practice effective ALS-specific nutrition management was also highlighted. Yet, there were mixed opinions about how well informed HCPs were and it was noted that the pre-gastrostomy period was the least well managed.

Just over 40% of survey respondents reported that they did not base their advice on guidelines or standards. Those that did referred mostly to the MNDA, NICE, PENG, ESPEN, and BAPEN. Many Trusts drew up their own guidance. The lack of ALS specific guidance for HCPs was cited as contributing to the variability in knowledge and practice in the focus groups. Participants stated that more education and formal guidance would help less knowledgeable professionals and facilitate the delivery of more standardized and effective nutritional management.

The importance of building relationships with pwALS was raised in every focus group, as well as the benefit of engaging patients at an early stage to facilitate high-quality nutritional management.

Commissioning of ALS services

Due to the complexities of achieving good nutritional care for people with ALS, there was a clear sense from focus group participants that one of the most important issues in successful nutritional management was the organizational and working approach adopted by both HCPs and commissioners.

A host of issues with commissioning were raised in each focus group, mostly relating to a perceived lack and inequality of specialized commissioning of nutrition management across areas, resulting in a “postcode lottery.”

Trying to understand how nutritional management services for pwALS are commissioned was a challenge across all parts of the study. Focus group participants described the commissioning for ALS as “illogical,” as it failed to recognize the time consuming nature of managing complex patients. This was reported to be particularly problematic for some dietitians, who were unable to allocate sufficient time to allow them to deal with the complex nutritional management of pwALS since their commissioning stipulated that they should spend 10–15 minutes in total with each patient. Dietitians reported facilitating the nutritional management for pwALS by practicing “good will” and opting to spend more time with them than they are commissioned for. Almost half of survey respondents believed that these services were given low (40.6%) or very low (6%) priority by commissioners. In general, there was a feeling from several focus group participants that, with better and more specific guidance about the need for nutritional management services in ALS, these services would be more likely to be commissioned

Organization and multidisciplinary team working

One of the most prominent topics raised in every focus group was the importance of implementing a multidisciplinary approach in order to deliver effective nutritional management.

Responses from the FOI request and survey suggested that the majority of organizations (73.2%) have an MDT. Although a dietitian was considered a member of the ALS MDT in 56 (79%) of organizations, only seven reported having ALS-specifically funded dietetic posts. Involvement in the MDT by all healthcare professions typically included attending regular meetings, whilst just over one quarter (26.2%) attended specialist ALS clinics.

One of the most important aspects of high functioning MDTs was effective communication between ALS professionals. Responses from the survey suggest that around half (52%) of HCPs think that communication about nutritional management is very or extremely effective. Furthermore, only 39% (n = 109) believe that care is very or extremely well-coordinated.

Discussion

The complexity of providing nutritional care to pwALS has been acknowledged throughout this study. Against this background, our research has identified a number of factors that influence the national delivery of nutritional management services for pwALS.

Organization of care has been identified as a key consideration in delivering quality healthcare to pwALS (14). Despite this, our study highlights geographical differences in ALS services and dietetic provision across the country. Whilst meeting the needs of the local community undoubtedly requires flexibility in healthcare delivery, the extent to which participants in this study reported inequities was apparent.

Taking a MDT approach was highlighted in this study as being central to coordinated health services, the benefits of which are known to positively impact on the quality of care and subsequent outcomes for pwALS (20–22). Although findings from our study suggest that the majority of organizations have an ALS MDT, the configuration and function varies. A major issue here is that for most HCPs in the MDT, providing healthcare to pwALS is only part of a much wider caseload. Only a small number of staff work in an ALS dedicated role. This is also the case for dietitians whose work is pivotal in providing more specialist nutritional care. Given the complex nature of the nutritional problems that pwALS experience, there is a case for having more specialist and advanced dietetic practitioners working in this area.

Another important aspect here is that whilst it seems that most HCPs provide nutritional advice to pwALS, in many cases, this is not standardized or driven by evidence-based guidelines. Furthermore, as a large proportion of individuals felt that their ALS nutrition knowledge could be improved, our findings emphasize a need for ALS-specific nutrition education and training, especially for non-specialist HCPs (non-dietitians or those outside of ALS MDTs). For Allied Health Professionals, reviewing current practice against the competency framework for progressive neurological conditions would be an ideal starting point to identifying continuing education and development needs for individuals and teams (23).

Finally, the timeliness of nutritional intervention is important. Despite nutritional issues often being present at diagnosis, our findings suggest that less than a third of pwALS are able to access dietetic services at this time. Given that the majority of MDTs report having a dietitian included, the reasons why many pwALS have to wait much longer to access specialist nutritional assessment and advice requires further exploration. Due to the nature of the disease, lack of timely intervention, alongside rapid progression of symptoms that impact on nutritional intake, is likely to contribute to deterioration in nutritional status. As highlighted previously, evidence suggests that pwALS who avoid losing weight during the course of the disease live longer (3). As recommended in national guidance (14), if pwALS are to have their nutritional status assessed, managed, and reviewed at each stage of the disease course, a review of staff resources is essential to facilitate more timely nutritional intervention. Particularly in light of the recent global pandemic and consequent impact on health care delivery, wider use of remote care using novel technology, such as video-conferencing, should also be explored (24).

Central to the development of specialist services for pwALS is funding and commissioning. Our findings suggest that, for people working in UK MND services, this process is unclear. It is likely that this confusion, particularly with regards to nutrition services, acts as a barrier to addressing the inequity in provision of nutritional care of pwALS.

Strengths and limitations

To our knowledge, this is the first study to extensively explore the national delivery of nutritional management services to pwALS. Using a three-part mixed-methods approach, we have been able to gain a deeper insight into how the variability in services impacts on HCPs working with pwALS across the country. Furthermore, given the number and geographical spread of participants that took part, we believe that we have captured a national snapshot of the structure of nutritional management services in the UK. There were, however, some gaps in our data. Although response rate to the FOI requests was high, the level of data collected varied considerably between organizations due to information not being available.

Implications for practice

Although this study focused on the provision of nutritional management services for pwALS in the UK, we believe that many of the overarching themes that we identified are likely to be paralleled in other countries. Key action points for practice have been summarized in Table 6. While research is required to chart the structure of dietetic services for pwALS in other countries, these action points may contribute to the development of high quality nutritional management services for pwALS globally.

Table 6.

Action points for practice.

Theme Action point Purpose
Access to dietetic services Setting of national minimum standards for nutritional management of pwALS, including referral to dietetic services at diagnosis To drive commissioning and timely, equal access to services
Organization and multidisciplinary team working Local review of the MDT membership with the inclusion of a dietitian as a core member  Increased number of specialist and advanced dietetic practitioners working with pwALS
Local evaluation of MDT communication and coordination of care, from the healthcare professional and patient perspective To optimize the effectiveness of MDT working, with an overall goal of improving outcomes for pwALS
Nutrition knowledge and skills Development of evidence based national nutritional guidelines specifically for pwALS, from diagnosis and throughout the disease course To improve the standard of  nutritional care for pwALS with increased awareness of the benefits of providing nutritional support  
National coordination of ALS-specific nutrition education and training, developed from the scientific evidence base, aimed primarily at non-specialist HCPs (non-dieticians or those outside of ALS MDT) To ensure all healthcare professionals are providing evidence based nutritional advice to pwALS

Conclusions

Our findings suggest that the development of evidence-based national guidelines for nutritional management in ALS, particularly at the time of diagnosis and pre-gastrostomy, could drive standardization of high-quality nutritional care, reduce inequities in services, and inform further nutrition education and training for HCPs. Furthermore, we believe that to reduce geographical variability, there is a need to improve understanding and transparency of the commissioning process of nutritional services for ALS in the UK.

Acknowledgements

The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Funding Statement

This work was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme [Grant Reference Number RP-PG-1016-20006] and supported by the NIHR Sheffield Biomedical Research Centre.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

References

  • 1.Marin B, Arcuti S, Jesus P, Logroscino G, Copetti M, Fontana A, French register of ALS in Limousin (FRALim), et al. Population-based evidence that survival in amyotrophic lateral sclerosis is related to weight loss at diagnosis neurodegenerative. Neurodegener Dis. 2016;16:225–34. [DOI] [PubMed] [Google Scholar]
  • 2.Ning P, Yang B, Li S, Mu X, Shen Q, Hu F, et al. Systematic review of the prognostic role of body mass index in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener.2019;20:356–67. [DOI] [PubMed] [Google Scholar]
  • 3.Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, et al. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol. 2019;266:1412–20. [DOI] [PubMed] [Google Scholar]
  • 4.Korner S, Hendricks M, Kollewe K, Zapf A, Dengler R, Silani V, et al. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dupuis L, Oudart H, René F, Gonzalez de Aguilar J-L, Loeffler J-P.. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA. 2004;101:11159–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Spataro R, Ficano L, Piccoli F, La Bella V.. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;304:44–8. [DOI] [PubMed] [Google Scholar]
  • 7., Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75. [DOI] [PubMed] [Google Scholar]
  • 8.Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Quality Standards Subcommittee of the American Academy of Neurology, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1227–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311–23. [DOI] [PubMed] [Google Scholar]
  • 10.NICE . Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition 2006. [online]. Available at: https://www.nice.org.uk/guidance/cg32. Accessed October 2019.
  • 11.O'Brien MR. Healthcare professionals' knowledge of motor neurone disease. Br J Nurs. 2004;13:1080–4. [DOI] [PubMed] [Google Scholar]
  • 12.Rio A, Cawadias E.. Nutritional advice and treatment by dietitians to patients with amyotrophic lateral sclerosis/motor neurone disease: a survey of current practice in England, Wales, Northern Ireland and Canada. J Hum Nutr Diet. 2007;20:3–13. [DOI] [PubMed] [Google Scholar]
  • 13.Zhang M, Hubbard J, Rudnicki SA, Johansen CS, Dalton K, Heiman-Patterson T, et al. Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis. Espen J. 2013;8:e25–e8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.NICE . Motor neurone disease: assessment and management. 2016. [online]. Available at: https://www.nice.org.uk/guidance/ng42. Accessed September 2020.
  • 15.Medical Research Council A framework for development and evaluation of RCTs for complex interventions to improve health. 2000. [online]. Available at https://mrc.ukri.org/documents/pdf/rcts-for-complex-interventions-to-improve-health/. Accessed September 2020.
  • 16.O'Cathain A, Murphy E, Nicholl J.. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341:c4587–1150. [DOI] [PubMed] [Google Scholar]
  • 17.Braun V, Clarke V.. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. [Google Scholar]
  • 18.Zarotti N, Coates E, McGeachan Williams I, Beever D, Hackney G, Norman P, on behalf of the HighCALS Study Group, et al. Health care professionals' views on psychological factors affecting nutritional behaviour in people with motor neuron disease: a thematic analysis. Br J Health Psychol. 2019;24:953–69. [DOI] [PubMed] [Google Scholar]
  • 19.Aridegbe T, Kandler R, Walters S, Walsh T, Shaw P, McDermott C.. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener.2013;14:13–9. [DOI] [PubMed] [Google Scholar]
  • 20.White S, Zarotti N, Beever D, Bradburn M, Norman P, Coates E, et al. , on behalf of the HighCALS Study Group. The nutritional management of people living with amyotrophic lateral sclerosis (ALS): a national survey of dietitians. n.d. (under review). [DOI] [PubMed] [Google Scholar]
  • 21.Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, et al. multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry. 2015;86:496–501. [DOI] [PubMed] [Google Scholar]
  • 22.Hogden A, Foley G, Henderson R, James N, Aoun SM.. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:205–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.MNDA, MS Trust and Parkinson’s UK . Allied health professionals competency framework for progressive neurological conditions. 2018. [online]. Available at: https://www.mndassociation.org/allied-health-professionals-competency-framework/. Accessed September 2020.
  • 24.Bloem BR, Dorsey ER, Okun MS.. The Coronavirus disease 2019 crisis as catalyst for telemedicine for chronic neurological disorders. JAMA Neurol. 2020;77:927–8. [DOI] [PubMed] [Google Scholar]

Articles from Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration are provided here courtesy of Taylor & Francis

RESOURCES